Our Group organises 3000+ Global Events every year across USA, Europe & Asia with support from 1000 more scientific Societies and Publishes 700+ 黑料网 Journals which contains over 50000 eminent personalities, reputed scientists as editorial board members.
The conventional technique of G-banded chromosome analysis reliably detects large chromosomal abnormalities and
rearrangements at a minimum size of about 3-10 Mb, and requires dividing cells. Its main limitation is that smaller
chromosomal deletions or duplications may be overlooked. Fluorescence in situ hybridization (FISH) was developed to rapidly
detect smaller chromosomal abnormalities with locus-specific probes, but one must clinically suspect a specific diagnosis
associated with a particular chromosome or chromosomal region to request the appropriate probe. Array-based comparative
genomic hybridization (aCGH) developed as a method to examine the entire genome for copy number changes caused by
deletions, duplications, or whole chromosome aneuploidy. It improved resolution over conventional G-banded karyotype in
detecting much smaller chromosomal abnormalities, as small as 50 to 100 kb, and does not require dividing cells. It has become
a first-line diagnostic tool for the detection of chromosome abnormalities at both macro and micro level in postnatal, highrisk
pregnancies and in products of conception samples. Application of these technologies in cancer research has produced a
wealth of useful information about copy number alterations (CNAs), Loss of heterozygosity (LOH) and mutations of specific
genes and their implications in cancer classification, disease progression, therapy response, and patient outcome. There is an
increasing interest in the genetic diagnostic community in applying this new technology for cancer diagnosis. Our experience
on more than 4000 cases performed using the aCGH, and aCGH and SNP arrays in postnatal, prenatal and cancer will be
presented.